Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit:: Role of treatment with Mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA

被引:84
作者
Sandri, Ana Maria
Dalarosa, Micheline Gisele
de Alcantara, Luciana Ruschel
Elias, Laura da Silva
Zavascki, Alexandre Prehn
机构
[1] Pontificia Univ Catolica Rio Grande Do Sul, Hosp Sao Lucas, Serv Infectiol, BR-90610000 Porto Alegre, RS, Brazil
[2] Pontificia Univ Catolica Rio Grande Do Sul, Hosp Sao Lucas, Infect Control Dept, Porto Alegre, RS, Brazil
[3] Pontificia Univ Catolica Rio Grande Do Sul, Hosp Sao Lucas, Infect Dis Unit, Porto Alegre, RS, Brazil
关键词
D O I
10.1086/500625
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
After the introduction of routine treatment for every nasal carrier of methicillin-resistant Staphylococcus aureus, active follow-up surveillance for nosocomial methicillin-resistant S. aureus infection was conducted for 5 years in an intensive care unit of a tertiary-care teaching hospital. There was a significant decrease in the incidence of nosocomial methicillin-resistant S. aureus infection during the later years of follow-up. Decolonization of nasal carriers of methicillin-resistant S. aureus is probably associated with such findings.
引用
收藏
页码:185 / 187
页数:3
相关论文
共 9 条
[1]  
Boelaert JR, 1996, INFECT CONT HOSP EP, V17, P809
[2]   Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients [J].
Corbella, X ;
Dominguez, MA ;
Pujol, M ;
Ayats, J ;
Sendra, M ;
Pallares, R ;
Ariza, J ;
Gudiol, F .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (05) :351-357
[3]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[4]   Surgical site infections in orthopedic surgery: The effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study [J].
Kalmeijer, MD ;
Coertjens, H ;
van Nieuwland-Bollen, PM ;
Bogaers-Hofman, D ;
de Baere, GAJ ;
Stuurman, A ;
van Belkum, A ;
Kluytmans, JAJW .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (04) :353-358
[5]  
Kluytmans JAJW, 1996, INFECT CONT HOSP EP, V17, P780
[6]  
National Committee for Clinical Laboratory Standards (NCCLS), 2000, NCCLS document M2-A7, V7th
[7]   Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains [J].
Pujol, M ;
Pena, C ;
Pallares, R ;
Ariza, J ;
Ayats, J ;
Dominguez, MA ;
Gudiol, F .
AMERICAN JOURNAL OF MEDICINE, 1996, 100 (05) :509-516
[8]   Nasal carriage as a source of Staphylococcus aureus bacteremia. [J].
von Eiff, C ;
Becker, K ;
Machka, K ;
Stammer, H ;
Peters, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :11-16
[9]   Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients [J].
Wertheim, HFL ;
Vos, MC ;
Ott, A ;
Voss, A ;
Kluytmans, JAJW ;
Vandenbroucke-Grauls, CMJE ;
Meester, MHM ;
van Keulen, PHJ ;
Verbrugh, HA .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (06) :419-425